SUBJECT TO COMPLETION, DATED JUNE 29, 2026 PRELIMINARY PROSPECTUS SUPPLEMENT(To Prospectus dated June 29, 2026) Shares of Common Stock Pursuant to this prospectus supplement and the accompanying prospectus, we are offeringvalue $0.00001 per share (“common stock”). shares of our common stock, par Our common stock is listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “MAMA.” On June 26, 2026, the lastreported sale price of our common stock was $19.94 per share. Investing in our securities involves a high degree of risk. You should read this prospectus supplement and the accompanyingprospectus as well as the information incorporated herein and therein by reference carefully before you make your investmentdecision. See “Risk Factors” beginning on page S-4 of this prospectus supplement and on page 5 of the accompanyingprospectus. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of thesesecurities or passed upon the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Anyrepresentation to the contrary is a criminal offense. (1)For information about additional underwriting compensation and the expenses for which we have agreed to reimburse theunderwriters in connection with this offering, see “Underwriting” beginning on pageS-10of this prospectus supplement. We have granted the underwriters the option to purchase up to an additionalshares of common stock on the same termsand conditions set forth above within 30 days from the date of this prospectus supplement to cover over-allotments, if any, inconnection with this offering. Joint Book-Running Managers William Blair D.A. Davidson & Co. Co-Managers Roth Capital Partners , 2026. TABLE OF CONTENTS Prospectus Supplement PageAbout this Prospectus SupplementS-1Prospectus Supplement SummaryS-2The OfferingS-3Risk FactorsS-4Special Note Regarding Forward-Looking StatementsS-6Use of ProceedsS-7Dividend PolicyS-8DilutionS-9UnderwritingS-10Where You Can Find More InformationS-17Incorporation by ReferenceS-17Legal MattersS-18ExpertsS-18 Prospectus PageAbout this Prospectus1Prospectus Summary2Risk Factors5Special Note Regarding Forward-Looking Statements5Use of Proceeds6Plan of Distribution7Description of Capital Stock9Description of Warrants12Description of Debt Securities13Description of Units19Legal Ownership of Securities20Where You Can Find More Information23Incorporation by Reference23Legal Matters24Experts24 You should rely only on the information we have provided or incorporated by reference in this prospectus supplement and theaccompanying prospectus. We have not, and the underwriters have not, authorized anyone to provide you with informationdifferent from that contained or incorporated by reference in this prospectus supplement or the accompanying prospectus. This prospectus supplement and any later prospectus supplement is an offer to sell only the securities offered hereby, but onlyunder circumstances and in jurisdictions where it is lawful to do so. You should assume that the information contained in this prospectus supplement and in any other prospectus supplement isaccurate only as of their respective dates and that any information we have incorporated by reference is accurate only as of thedate of the document incorporated by reference, regardless of the time of delivery of this prospectus supplement or any otherprospectus supplement for any sale of securities. ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement is part of an automatic shelf registration statement that we filed with the Securities and ExchangeCommission (the “SEC”) as a “well-known seasoned issuer” as defined in Rule 405 under the Securities Act of 1933, as amended (the“Securities Act”), using a “shelf” registration process. By using a shelf registration statement, we may offer an unspecified amount ofsecurities from time to time under this prospectus supplement. This document is in two parts. The first part is this prospectussupplement, which describes the specific terms of this common stock offering and also adds to and updates information contained inthe accompanying prospectus and the documents incorporated by reference herein and therein. The second part, the accompanyingprospectus, provides more general information. To the extent there is a conflict between the information contained in this prospectussupplement and the information contained in the accompanying prospectus or any document incorporated by reference therein filedprior to the date of this prospectus supplement, you should rely on the information in this prospectus supplement; provided that if anystatement in one of these documents is inconsistent with a statement in another document having a later date—for example, adocument incorporated by reference in the accompanying prospectus—the statement in the document having the later date modifies orsupersedes the earlier statement. We further not